相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Variable roles of interleukin-17F in different cancers
Tiina Mikkola et al.
BMC CANCER (2022)
An Immunosenescence-Related Gene Signature to Evaluate the Prognosis, Immunotherapeutic Response, and Cisplatin Sensitivity of Bladder Cancer
Ranran Zhou et al.
DISEASE MARKERS (2022)
A Four-Cell-Senescence-Regulator-Gene Prognostic Index Verified by Genome-Wide CRISPR Can Depict the Tumor Microenvironment and Guide Clinical Treatment of Bladder Cancer
Jian-Xuan Sun et al.
FRONTIERS IN IMMUNOLOGY (2022)
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update
Morgan Roupret et al.
EUROPEAN UROLOGY (2021)
Cellular senescence in cancer: from mechanisms to detection
Hui-Ling Ou et al.
MOLECULAR ONCOLOGY (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
MYC as a target for cancer treatment
Michael J. Duffy et al.
CANCER TREATMENT REVIEWS (2021)
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
Raffaella Di Micco et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2021)
Advances in Immunotherapy and the TGF-β Resistance Pathway in Metastatic Bladder Cancer
David J. Benjamin et al.
CANCERS (2021)
Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
Ruchi Kumari et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Inflammation, Extracellular Matrix Remodeling, and Proteostasis in Tumor Microenvironment
Marina Marozzi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
CBX7 suppresses urinary bladder cancer progression via modulating AKR1B10-ERK signaling
Zhengnan Huang et al.
CELL DEATH & DISEASE (2021)
Interplay and cooperation between SREBF1 and master transcription factors regulate lipid metabolism and tumor-promoting pathways in squamous cancer
Li-Yan Li et al.
NATURE COMMUNICATIONS (2021)
A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer
Libo Yang et al.
FRONTIERS IN ONCOLOGY (2021)
Targeting the interleukin-17 immune axis for cancer immunotherapy
Gerardo A. Vitiello et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Cellular senescence and senescence-associated secretory phenotype via the cGAS-STING signaling pathway in cancer
Tze Mun Loo et al.
CANCER SCIENCE (2020)
TGF-beta: a master immune regulator
Christopher Larson et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2020)
Development of an autophagy-related gene expression signature for prognosis prediction in prostate cancer patients
Daixing Hu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Immune checkpoint inhibition in muscle-invasive and locally advanced bladder cancer
Kilian M. Gust et al.
CURRENT OPINION IN UROLOGY (2020)
Role of the Innate Immune System in the Development, Progression, and Therapeutic Response of Bladder Cancer
Jorge Daza et al.
European Urology Focus (2020)
Exosome-mediated Hic-5 regulates proliferation and apoptosis of osteosarcoma via Wnt/β-catenin signal pathway
Liansheng Sha et al.
Aging-US (2020)
CRYAB inhibits migration and invasion of bladder cancer cells through the PI3K/AKT and ERK pathways
Houxin Ruan et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2020)
How the ageing microenvironment influences tumour progression
Mitchell Fane et al.
NATURE REVIEWS CANCER (2020)
CELLULAR SENESCENCE: AGING, CANCER, AND INJURY
Arianna Calcinotto et al.
PHYSIOLOGICAL REVIEWS (2019)
Cellular Senescence and the Immune System in Cancer
Luis I. Prieto et al.
GERONTOLOGY (2019)
Pas de Deux: Control of Anti-tumor Immunity by Cancer-Associated Inflammation
Shabnam Shalapour et al.
IMMUNITY (2019)
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
Florian R. Greten et al.
IMMUNITY (2019)
Transcriptome signature of cellular senescence
Gabriel Casella et al.
NUCLEIC ACIDS RESEARCH (2019)
TGF-β-induced transgelin promotes bladder cancer metastasis by regulating epithelial-mesenchymal transition and invadopodia formation
Zhicong Chen et al.
EBIOMEDICINE (2019)
Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy
Huiying Han et al.
CANCER CELL (2019)
HIC-5 in cancer-associated fibroblasts contributes to esophageal squamous cell carcinoma progression
Xuanling Du et al.
CELL DEATH & DISEASE (2019)
Cellular Senescence and Anti-Cancer Therapy
Jieqiong You et al.
CURRENT DRUG TARGETS (2019)
Senescence-associated reprogramming promotes cancer stemness
Maja Milanovic et al.
NATURE (2018)
Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial
Manish R. Patel et al.
LANCET ONCOLOGY (2018)
Hic-5 expression is a major indicator of cancer cell morphology, migration, and plasticity in three-dimensional matrices
Anushree C. Gulvady et al.
MOLECULAR BIOLOGY OF THE CELL (2018)
PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux
Jake S. O'Donnell et al.
SEMINARS IN CANCER BIOLOGY (2018)
Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer
Yang-An Wen et al.
CELL DEATH & DISEASE (2018)
LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers
Sylvie Maubant et al.
Oncotarget (2018)
Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline
Tyler J. Bussian et al.
NATURE (2018)
Hic-5 remodeling of the stromal matrix promotes breast tumor progression
G. J. Goreczny et al.
ONCOGENE (2017)
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
Arjun V. Balar et al.
LANCET (2017)
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
Arjun V. Balar et al.
LANCET ONCOLOGY (2017)
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
J. Bellmunt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Hic-5 regulates epithelial to mesenchymal transition in ovarian cancer cells in a TGFβ1-independent manner
Razan Sheta et al.
ONCOTARGET (2017)
Bladder cancer
Oner Sanli et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma Updated Results From a Phase 1/2 Open-label Study
Thomas Powles et al.
JAMA ONCOLOGY (2017)
Senescence in Health and Disease
Shenghui He et al.
CELL (2017)
Small molecule compounds that induce cellular senescence
Nadezhda V. Petrova et al.
AGING CELL (2016)
Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression
Tobias Eggert et al.
CANCER CELL (2016)
Hic-5 deficiency attenuates the activation of hepatic stellate cells and liver fibrosis through upregulation of Smad7 in mice
Xiao-Feng Lei et al.
JOURNAL OF HEPATOLOGY (2016)
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E. Rosenberg et al.
LANCET (2016)
Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial
Padmanee Sharma et al.
LANCET ONCOLOGY (2016)
Tissue damage and senescence provide critical signals for cellular reprogramming in vivo
Lluc Mosteiro et al.
SCIENCE (2016)
Conditional ablation of TGF-β signaling inhibits tumor progression and invasion in an induced mouse bladder cancer model
Yu Liang et al.
SCIENTIFIC REPORTS (2016)
Role of Hic-5 in the formation of microvilli-like structures and the monocyte-endothelial interaction that accelerates atherosclerosis
Shigeko Arita-Okubo et al.
CARDIOVASCULAR RESEARCH (2015)
Matrix metalloproteinase-10 promotes tumor progression through regulation of angiogenic and apoptotic pathways in cervical tumors
Ge Zhang et al.
BMC CANCER (2014)
An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Marco Demaria et al.
DEVELOPMENTAL CELL (2014)
Senescence Is a Developmental Mechanism that Contributes to Embryonic Growth and Patterning
Mekayla Storer et al.
CELL (2013)
Elevated IL-17A levels in early stages of bladder cancer regardless of smoking status
Mehrnoosh Doroudchi et al.
FUTURE ONCOLOGY (2013)
Activation of Androgen Receptor, Lipogenesis, and Oxidative Stress Converged by SREBP-1 Is Responsible for Regulating Growth and Progression of Prostate Cancer Cells
Wen-Chin Huang et al.
MOLECULAR CANCER RESEARCH (2012)
Overview of the Matrisome-An Inventory of Extracellular Matrix Constituents and Functions
Richard O. Hynes et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases
Rajita Pappu et al.
IMMUNOLOGY (2011)
Four faces of cellular senescence
Francis Rodier et al.
JOURNAL OF CELL BIOLOGY (2011)
Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancer
Tibor Szarvas et al.
CANCER SCIENCE (2010)
Loss of the CBX7 protein expression correlates with a more aggressive phenotype in pancreatic cancer
Eva Karamitopoulou et al.
EUROPEAN JOURNAL OF CANCER (2010)
The loss of the CBX7 gene expression represents an adverse prognostic marker for survival of colon carcinoma patients
Pierlorenzo Pallante et al.
EUROPEAN JOURNAL OF CANCER (2010)
SENESCENCE Senescence in tumours: evidence from mice and humans
Manuel Collado et al.
NATURE REVIEWS CANCER (2010)
Eph receptors and ephrins in cancer: bidirectional signalling and beyond
Elena B. Pasquale
NATURE REVIEWS CANCER (2010)
IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway
Lin Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Identification of a novel serine/threonine kinase that inhibits TNF-induced NF-κB activation and p53-induced transcription
J Huang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
分享论文
